Results 241 to 250 of about 27,708,048 (352)

Dual diagnosis of acidification dynamics in Amazonian urban lakes: multivariate analysis and calcite saturation index for status and vulnerability assessment. [PDF]

Environ Monit Assess
Noriega C, Romão C, Aquino R, Monteiro S, Moraes B, Brito R, Medeiros C, Rollnic M, Araujo M.   +8 more
europepmc   +1 more source

Added Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the added prognostic value of EEG reactivity for favorable outcome compared with background analysis during and after targeted temperature management (TTM). Methods Prospective observational cohort study of comatose post–cardiac arrest patients admitted to a single academic center between 2017 and 2022, all undergoing ...
Sarah Caroyer, Marie Obrecht, Charlotte de Maeseneire, Charlotte Damien, Chantal Depondt, Lorenzo Ferlini, Estelle Rikir, Filippo Annoni, Fabio Silvio Taccone, Nicolas Mavroudakis, Benjamin Legros, Nicolas Gaspard   +11 more
wiley   +1 more source

Three‐dimensional numerical simulations of crustal systems undergoing orogeny and subjected to surface processes

, 2014
C. Thieulot, P. Steer, R. Huismans
semanticscholar   +1 more source

Nanofiltration for the Removal of Micropollutants from Surface Water and UV/PAA Oxidation of the Resulting Retentate. [PDF]

Materials (Basel)
Bolińska MI, Piekutin J, Kotowska U.
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Process Optimization and Microstructure-Property Regulation of P20 Plastic Mold Steels. [PDF]

Materials (Basel)
Zhao L, Hou Z, Xing C, Yang M, Yan J, Li Z, Yao Z.   +6 more
europepmc   +1 more source

Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi, Kenichiro Taira, Masanori Kurihara, Kenji Ishibashi, Kenji Ishii, Fumio Suzuki, Aya Midori Tokumaru, Makoto Hara, Atsushi Iwata   +8 more
wiley   +1 more source

Active Bromine Cycling Enables Bromate as an Oxidant of Mn(II) on the Low-Temperature Martian Surface. [PDF]

Inorg Chem
Qu SY, Zhao YS, Lin H, Yin Y, Yang X, Yu XW, Yang L, Zhang C, He H.   +8 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Microplastics-Pollutant Interactions in Environmental Systems: Mechanisms, Ecological Effects, and Implications for Sustainable Management. [PDF]

Molecules
Wu L, Zhou X, Lai C, Ma M, Qin L, Wang W.   +5 more
europepmc   +1 more source